079 * VIDEO-ASSISTED MEDIASTINOSCOPIC LYMPHADENECTOMY COMBINED WITH VIDEO-ASSISTED THORACIC SURGERY FOR LEFT-SIDED LUNG CANCER: EXPERIENCE FROM 225 CONSECUTIVE CASES
Objectives: Video-assisted mediastinoscopic lymphadenectomy (VAMLA) has immensely increased the accuracy of mediastinal staging in the treatment of lung cancer. However, the question remains as to whether its safety and accuracy can be consistently replicable, which limits widespread adoption of this technique. We report 225 consecutive cases of VAMLA combined with video-assisted thoracic surgery (VATS) pulmonary resection in patients with left-sided lung cancer. Methods: From 2002 to 2013, a total of 1685 patients underwent VATS lobectomy due to lung cancer at the Asan Medical Center. Among them, we identified 225 patients with left-sided lung cancer who underwent concomitant VAMLA. Procedural time, sampled nodal stations, number of biopsies and procedural complications related to VAMLA were evaluated. Results: There was no early deaths, and recurrent laryngeal nerve palsy occurred in 10 patients (4.4%). The lymph nodal dissection of station 2R, 2L, 4R, and 4L was performed in 15.1%, 12.4%, 42.7%, and 87.6% of the total patients, respectively. The lymph nodal dissection of station 7, however, was performed in 100% of the patients. The mean number of biopsies and sampled nodal stations was 29.7 and 2.6, respectively. The mean procedural time was 38.1 ± 12.3 min. The operative time for VATS lobectomy, compared with the patients undergoing left-sided VATS lobectomy without VAMLA during the same study period (n = 424), was significantly shorter in the VAMLA group (117.0 ± 40.4 vs 157.6 ± 33.0 min; P < 0.01). Conclusion: VAMLA appears to be a safe and effective supplementary technique which allows more accurate mediastinal staging and shorter single-lung ventilation time in patients with left-sided lung cancer undergoing minimally-invasive pulmonary resection.